
FidoCure® is the leader in Precision Medicine for Canine Oncology.
screenshot pendingFidoCure® is an innovative cancer-care service specifically designed for dogs, developed by One Health Company. The service utilizes advanced genomic testing to create personalized treatment plans for canine cancer patients, moving beyond traditional chemotherapy and radiation therapies. This approach recognizes that there is no universal treatment for cancer, as each case is unique and requires tailored interventions to improve outcomes for affected dogs. FidoCure® aims to provide a more effective and hopeful prognosis through its personalized therapeutics, which are based on genomic insights…